Urologic Disorders are Still the Leading Cause of In-hospital Death in Patients With Spina Bifida.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 21 07 2019
revised: 06 11 2019
accepted: 07 11 2019
pubmed: 18 11 2019
medline: 13 3 2020
entrez: 18 11 2019
Statut: ppublish

Résumé

To assess and analyze the contemporary causes of in-hospital deaths of spina bifida patients. It was a cross-sectional observational study of the longitudinal national cohort of all patients hospitalized in French public and private hospitals. We analyzed the data from the French hospital discharge database (Programme de Médicalisation des Systemes d'Information, PMSI) from 2009 to 2014. The number of in-hospital deaths was extracted using the combination of the ICD-10 codes "Q05" or "Q760" and a discharge code = 9. There were 138 in-hospital deaths of spina bifida patients over the 6-year study period. The median age at death was 41 years (IQR: 25-52). The median age at death was significantly lower in patients with vs without hydrocephalus (26.6 vs 45.5 years; P <.0001). The leading cause of in-hospital death was urologic disorders (n = 24; 17.3%). Other main causes of death were pulmonary disorders (n = 23; 16.7%), neurologic disorders (n = 19; 13.8%), and bowel disorders (n = 15; 10.9%). Upper urinary tract damage accounted for most of the urologic causes of death: 8 patients died from urinary tract infections (33.3%), 7 patients died from renal failure (29.2%), 4 died from bladder cancer (16.7%), and 5 from other urologic causes. The only variable significantly associated with a death from urologic causes was the absence of hydrocephalus (OR = 0.26; P = .009). Urologic disorders remain the leading cause of in-hospital death in spina bifida patients in France. The present study highlights that efforts to improve the urologic management of the spina bifida population are still greatly needed.

Identifiants

pubmed: 31734348
pii: S0090-4295(19)30976-8
doi: 10.1016/j.urology.2019.11.006
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

200-204

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Benoit Peyronnet (B)

Service d'urologie, CHU Rennes, Rennes, France; Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France. Electronic address: peyronnetbenoit@hotmail.fr.

Fei Gao (F)

EHESP Rennes, Sorbonne Paris Cité, Paris, France.

Charlène Brochard (C)

Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France; Service de Gastro-Entérologie, CHU Rennes, Rennes, France.

Emmanuel Oger (E)

Univ Rennes, CHU Rennes, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) Rennes, France.

Lucie-Marie Scailteux (LM)

Univ Rennes, CHU Rennes, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) Rennes, France.

Frédéric Balusson (F)

Univ Rennes, CHU Rennes, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) Rennes, France.

Juliette Hascoet (J)

Service d'urologie, CHU Rennes, Rennes, France; Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France.

Quentin Alimi (Q)

Service d'urologie, CHU Rennes, Rennes, France; Centre de référence spina bifida, CHU Rennes, Rennes, France.

Zine-Eddine Khene (ZE)

Service d'urologie, CHU Rennes, Rennes, France.

Sahar Bayat (S)

EHESP Rennes, Sorbonne Paris Cité, Paris, France.

Magali Jezequel (M)

Centre de référence spina bifida, CHU Rennes, Rennes, France.

Camille Olivari (C)

Centre de référence spina bifida, CHU Rennes, Rennes, France.

Caroline Voiry (C)

Centre de référence spina bifida, CHU Rennes, Rennes, France; Service de Médecine Physique et Réadaptation, CHU Rennes, Rennes, France.

Jacques Kerdraon (J)

Centre de référence spina bifida, CHU Rennes, Rennes, France; Centre de rééducation de Kerpape, Ploemeur, France.

Guillaume Bouguen (G)

Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France; Service de Gastro-Entérologie, CHU Rennes, Rennes, France.

Xavier Game (X)

Département d'Urologie, Transplantation Rénale et Andrologie, CHU Rangueil, Toulouse, France.

Laurent Siproudhis (L)

Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France; Service de Gastro-Entérologie, CHU Rennes, Rennes, France.

Andrea Manunta (A)

Service d'urologie, CHU Rennes, Rennes, France; Centre de référence spina bifida, CHU Rennes, Rennes, France; Equipe thématique INPHY CIC 1414 et INSERM UMR 1241, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH